Statistical Methods for Bioavailability and Bioequivalence
- 1 January 1983
- journal article
- research article
- Published by Taylor & Francis in Clinical Research Practices and Drug Regulatory Affairs
- Vol. 1 (2), 109-132
- https://doi.org/10.3109/10601338309024010
Abstract
Four aspects of bioavailability are discussed: (i) a brief review of bioavailability and bioequivalence in pharmaceutical research in the past 20 years, (ii) statistical contributions to that research, especially in the 1970's, (iii) new statistical ideas in this application area in the first three years of the 1980 decade, and (iv) an evaluation of these new ideas, what is yet needed, and what might be done in the future.Keywords
This publication has 11 references indexed in Scilit:
- The Bioavailability of Erythromycin Stearate versus Enteric-Coated Erythromycin Base When Taken Immediately before and after FoodJournal of International Medical Research, 1981
- Bioequivalence Testing -- A Need to RethinkBiometrics, 1981
- Statistical Simulation Study of New Proposed Uniformity Requirement for Bioequivalency StudiesJournal of Pharmaceutical Sciences, 1981
- An aid to decision-making in bioequivalence assessmentJournal of Pharmacokinetics and Biopharmaceutics, 1981
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption timeJournal of Pharmacokinetics and Biopharmaceutics, 1980
- Determining the probability of an important difference in bioavailabilityClinical Pharmacology & Therapeutics, 1980
- Bioavailability of imipramine tablets relative to a stable isotope-labeled internal standard: Increasing the power of bioavailability testsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- Digoxin Bioavailability : Evaluation of a Generic Tablet and Proposed FDA GuidelinesJournal of Pharmaceutical Sciences, 1977
- A NOTE ON NORMAL CORRELATIONBiometrika, 1939